Health News Roundup: US Senate Democrats grill pharma CEOs on drug prices; Illumina forecasts flat 2024 sales as sluggish demand drags on and more devdiscourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from devdiscourse.com Daily Mail and Mail on Sunday newspapers.
Genetic medicines company Metagenomi Technologies said on Thursday it is aiming for a valuation of $563 million in its US initial public offering (IPO.
Genetic medicines company Metagenomi
Technologies said on Thursday it is aiming for a
valuation of $563 million in its U.S. initial public offering
, a number that is at the low end of its initial.